Neuralink Raises $600 Million, Reaching $9 Billion Valuation
Elon Musk's brain-computer interface company, Neuralink, has secured $600 million in new funding, elevating its pre-money valuation to $9 billion. This significant investment follows a previous round of $43 million raised in November 2023, when the company was valued at $5 billion.
The recent funding round was initially reported by Semafor, citing anonymous sources. While the investors remain undisclosed, this news confirms earlier reports from Bloomberg suggesting Neuralink was seeking a $500 million investment at an $8.5 billion valuation.
Neuralink's Progress and FDA Breakthrough
Neuralink achieved a significant milestone last year, receiving "breakthrough device" designation from the U.S. Food and Drug Administration (FDA). This designation expedited the review process for their innovative brain implant technology. To date, three individuals have received Neuralink implants.
Earlier this month, a nonverbal patient demonstrated the potential of Neuralink's technology by posting a video online. The video showcased the patient using the brain implant to edit and narrate YouTube videos using only brain signals. This highlights the potential of Neuralink's technology to restore communication and improve the lives of people with neurological conditions.
For more information about Neuralink's technology and progress:
- Semafor's report on the funding round
- TechCrunch's coverage of the previous funding round
- Reuters' report on Neuralink's earlier valuation
- Bloomberg's report on Neuralink's fundraising goals
- TechCrunch's article on Neuralink's FDA breakthrough designation
- Business Insider's story on the nonverbal patient using Neuralink
